Eland Oil & Gas appoints Henry Obi to the Board as Non-Executive Director

– UK, Aberdeen – Eland Oil & Gas PLC (AIM: ELA), an oil & gas production and development company operating in West Africa with an initial focus on Nigeria, today announces the appointment of Henry Obi to the Board as a Non-Executive Director representing Helios Natural Resources a significant shareholder in Eland. Henry will replace Richard Norris who has been Helios Natural Resources’ representative on the Board since September 2014. The Board thanks Richard for his valuable contribution and wishes him well for the future.

Henry Obi has over 15 years’ experience in private equity sector and is currently a Partner and Chief Operating Officer at Helios Investment Partners LLP where he responsible for its operations and serves on Helios’ Equity and Credit Investment Committees. Prior to joining Helios in 2006, Henry was a Partner at Aureos Advisers Limited where he was responsible for monitoring the performance of the firm’s funds in Africa and Central America and their compliance with investment policy. Prior to Aureos, Henry worked for Actis, CDC Group Plc and Dynegy, a US energy trader.

Henry holds a BSc. Architecture and MSc. Architecture from University of Nigeria, a B.Arch. from University of Nottingham and an MBA in Finance from the London Business School. He sits on the Boards of Maris Capital Limited and the Africa Venture Capital Association. He also served as Chairman of the Africa Regional Advisory Council of Emerging Market Private Equity Association. He received Private Equity Africa’s Outstanding Leadership Award in 2014 for his commitment to advancing the cause of private equity in Africa.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>